Downregulated MYL1 Emerges as a Promising Diagnostic Biomarker for Rheumatoid Arthritis

Chaoquan Yang, Zhiling Huang, Xifan Zheng, Haojun Tang, Wenpeng Qin, Yicheng Liang, Haidong Chen, Wenjun Hao, Dan Yi, William W Lu, Yan Chen · 2025

Read Downregulated MYL1 Emerges as a Promising Diagnostic Biomarker for Rheumatoid Arthritis by Chaoquan Yang, Zhiling Huang, Xifan Zheng, Haojun Tang, Wenpeng Qin, Yicheng Liang, Haidong Chen, Wenjun Hao, Dan Yi, William W Lu, Yan Chen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12720931.txt.

Description

Chaoquan Yang and co-authors flag a muscle protein that runs low in rheumatoid arthritis and might help diagnose it. Their 2025 study mines gene data from patients and healthy controls. The joint disease causes chronic pain and stays hard to manage.

Two selection methods singled out the protein's gene from the changed set. Its level was markedly lower in patients, and it separated patients from controls with strong accuracy. Pathway checks tied it to muscle building, immune control, and calcium signals. Immune cell mixes in blood also shifted with its level. A rat model of the disease confirmed the drop in both gene and protein form. The authors call for clinical tests of the marker.

Catalog record

CREATORChaoquan Yang, Zhiling Huang, Xifan Zheng, Haojun Tang, Wenpeng Qin, Yicheng Liang, Haidong Chen, Wenjun Hao, Dan Yi, William W Lu, Yan Chen
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12720931

Browse the full library · About the Tower of Babel